Enalapril maleate and Kidney transplant - a phase IV clinical study of FDA data

Summary:

Kidney transplant is reported as a side effect among people who take Enalapril maleate (enalapril maleate), especially for people who are male, 40-49 old, also take Furosemide, and have Anaemia.

The phase IV clinical study analyzes which people have Kidney transplant when taking Enalapril maleate. It is created by eHealthMe based on reports of 32,603 people who have side effects when taking Enalapril maleate from the FDA, and is updated regularly.

What is Enalapril maleate?

Enalapril maleate has active ingredients of enalapril maleate. It is often used in high blood pressure. eHealthMe is studying from 33,597 Enalapril maleate users. Check the latest studies of Enalapril maleate.

What is Kidney transplant?

Kidney transplant is found to be associated with 299 drugs and 548 conditions by eHealthMe. Check the latest studies of Kidney transplant.

On Jul, 31, 2026

32,603 people reported to have side effects when taking Enalapril maleate.
Among them, 18 people (0.06%) have Kidney transplant.

Could Enalapril maleate cause Kidney transplant?

Among these 18 people:

What is the gender of people who have Kidney transplant when taking Enalapril maleate? *

female: 47.06 %
male: 52.94 %

What is the age of people who have Kidney transplant when taking Enalapril maleate? *

What are other drugs people take besides Enalapril maleate? *

What are other side effects people have besides Kidney transplant? *

Acute Kidney Failure: 6 people, 33.33%
Ventricular Hypertrophy (enlargement of ventricles (lower chambers) in the heart): 5 people, 27.78%
Renal Artery Stenosis (narrowing of renal artery): 5 people, 27.78%
Vascular Pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity): 4 people, 22.22%
Excessive Or Unwanted Hair In Women: 4 people, 22.22%
Dysplasia (enlargement of an organ or tissue): 4 people, 22.22%
Drug Ineffective: 3 people, 16.67%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 16.67%
Red Cell Aplasia (a type of anaemia affecting the precursors to red blood cells): 3 people, 16.67%
Injection Site Urticaria (rash of round, red welts on the skin at injection site): 3 people, 16.67%

What are the existing conditions these people have? *

Anaemia (lack of blood): 4 people, 22.22%
Acute Kidney Failure: 3 people, 16.67%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 3 people, 16.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 11.11%
Body Height Below Normal: 2 people, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.56%
Blood Growth Hormone Decreased: 1 person, 5.56%
Blood Iron Decreased: 1 person, 5.56%
Blood Phosphorus Increased: 1 person, 5.56%
Transplant Rejection (a transplant material is not worked): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Enalapril maleate and have Kidney transplant?

- Check whether Kidney transplant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enalapril maleate:

Enalapril maleate (33,597 reports)

Browse all side effects of Enalapril maleate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Kidney transplant:

Kidney transplant (299 drugs)

Browse all the conditions that are associated with Kidney transplant:

Kidney transplant (548 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enalapril maleate (the active ingredients of Enalapril maleate) and Enalapril maleate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.